Patent · US Active

Triazolopyridines

US9676766B2 · kind B2 · utility

0Cited by

1References

14Claims

0Family size

Assignee

Bayer Intellectual Property GmbH · DE

Inventors

Volker Schulze · Hohen Neuendorf, DE
Marcus Koppitz · Berlin, DE
Dirk Kosemund · Berlin, DE
Hartmut Schirok · Wuppertal, DE
Benjamin Bader · Berlin, DE
Philip Lienau · Berlin, DE
Antje Margret Wengner · Berlin, DE
Hans Briem · Bremen, DE
Simon Holton · Berlin, DE
Gerhard Siemeister · Berlin, DE
Stefan Prechtl · Berlin, DE
Ulf Bömer · Glienicke, DE

Key dates

Filing date	Nov 17, 2010
Grant date	Jun 13, 2017
Priority date	—
Expiry date	Sep 12, 2031

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K31/5377
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to triazolopyridine compounds of general formula (I) which are Monopolar Spindle 1 kinase (Mps-1 or TTK) inhibitors: Formula (I), in which R1, R2, R3, R4, and R5 are as given in the description and in the claims, to methods of preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds, to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis proliferative of diseases, as well as to intermediate compounds useful in the preparation of said compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.